← All stocks

Wave Life Sciences, Inc.

WVE Net buying
CIK 0001631574 #2524 in the set updated 17 Sep 2026
Bought (12 mo)
$82.56M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$16.18M
$689.18K on a plan · $15.23M straight out of an exercise
Sold at will
$257.96K
4 of 47 sales
Net
+$66.38M
+$82.30M against sales at will

By person

13 insiders · 53 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$54.63M (5)
+$54.63M
26,975,505
13.69%
$142.70M
+48.3%
GSK plc entity
10% owner
$27.93M (1)
+$27.93M
18,245,691
9.26%
$96.52M
+30.5%
Francis Chris
See Remarks
$7.10M (14) scheduled
−$7.10M
61,867
0.0314%
$327.28K
−22.4%
Moran Kyle
Chief Financial Officer
$4.15M (7) scheduled
−$4.15M
134,385
0.0682%
$710.90K
+1,958%
Tan Aik Na
Director
$1.83M (9) scheduled
−$1.83M
24,968
0.0127%
$132.08K
+54.9%
HENRY CHRISTIAN O
Director
$1.37M (4) scheduled
−$1.37M
12,700
0.0064%
$67.18K
−21.2%
Rawcliffe Adrian
Director
$806.60K (3) scheduled
−$806.60K
0
0.0000%
$0.00
−100.0%
Verdine Gregory L.
Director
$269.46K (2) scheduled
−$269.46K
275,217
0.1397%
$1.46M
+390.5%
Wagner Heidi L
Director
$231.07K (3) scheduled
−$231.07K
44,930
0.0228%
$237.68K
+39.4%
CORRIGAN MARK
Director
$217.30K (2) scheduled
−$217.30K
28,815
0.0146%
$152.43K
−10.6%
BOLNO PAUL
President and CEO
$140.96K (1)
−$140.96K
275,520
0.1398%
$1.46M
−23.3%
Vargeese Chandra
See Remarks
$43.42K (1)
−$43.42K
408,246
0.2072%
$2.16M
+113.6%
TAKANASHI KEN
Director
$23.22K (1) scheduled
−$23.22K
9,626,487
4.89%
$50.92M
+68.3%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 35
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 5,245,178
History held since 14 Nov 2016